Physical function and fatigue recovery at 6 months after hospitalization for COVID ‐19
PM&R · 2023-03 · 15 (3) · 314-324
DOI: 10.1002/pmrj.12866 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 06.08.2022. Verfasst von Evelyn S Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Activities of Daily Living, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, U.S. Department of Veterans Affairs, Rheumatology Research Foundation.
Abstract (Originalsprache)
Introduction
There are an increasing number of individuals with long‐term symptoms of coronavirus‐19 disease (COVID‐19); however, the prognosis for recovery of physical function and fatigue after COVID‐19 is uncertain.
Objective
To report the changes in functional recovery between 1 and 6 months after hospitalization of adults hospitalized for COVID‐19 and explore the baseline factors associated with physical function recovery.
Design
A prospective cohort study.
Setting
Tertiary care hospital.
Participants
U.S. adult COVID‐19 survivors.
Intervention
N/A. Main Outcome Measures Telephone interviews assessed three outcome domains: basic and instrumental activities of daily living (ADLs) performance, fatigue, and general physical function (Health Assessment Questionnaire [HAQ]).
Results
The age of participants (n = 92) ranged from 22 to 95 years (54.3 ± 17.2). Across outcome domains, a majority (63%–67%) of participants developed new ADL impairment, fatigue, or worsening HAQ severity by 1 month. Of those, 50%–79% partially or fully recovered by 6 months, but 21%–50% did not recover at least partially. Fifteen to 30% developed new impairment between 1 and 6 months. For those without any improvement in ADL impairments at 6 months, lower socioeconomic status was significantly more common ( p = .01) and age ≥ 65 ( p = .06), trending toward being more common.
Conclusion
In this cohort, a substantial proportion of the participants who developed new ADL impairment, worsening fatigue, or HAQ severity after hospitalization for COVID‐19 did not recover at least partially by 6 months after discharge. Evaluating functional status 1 month after discharge may be important in understanding functional prognosis and recovery after hospitalization for COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA.
- Department of Radiology, University of Washington, Seattle, Washington, USA.
- Department of Medicine, University of Washington, Seattle, Washington, USA.
- VA Puget Sound Health Care System, Seattle, Washington, USA.
- Department of Medicine, Oregon Health & Science University, Oregon, Portland, USA.
- Department of Neurology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Evelyn S Qin, Laura S Gold, Aaron E Bunnell
Förderung
- NIA NIH HHS
- U.S. Department of Veterans Affairs
- Rheumatology Research Foundation
- Institute of Aging
- National Institutes of Health
Zitieren
APA
Qin, E. S., Gold, L. S., Singh, N., Wysham, K. D., Hough, C. L., Patel, P. B., Bunnell, A. E., & Andrews, J. S. (2023). Physical function and fatigue recovery at 6 months after hospitalization for COVID ‐19. PM&R, 15(3), 314-324. https://doi.org/10.1002/pmrj.12866
Vancouver
Qin ES, Gold LS, Singh N, Wysham KD, Hough CL, Patel PB, et al. Physical function and fatigue recovery at 6 months after hospitalization for COVID ‐19. PM&R. 2023;15(3):314-324. doi:10.1002/pmrj.12866
BibTeX
@article{Qin2023,
author = {Qin, Evelyn S and Gold, Laura S and Singh, Namrata and Wysham, Katherine D and Hough, Catherine L and Patel, Payal B and Bunnell, Aaron E and Andrews, James S},
title = {Physical function and fatigue recovery at 6 months after hospitalization for COVID ‐19},
journal = {PM&R},
year = {2023},
volume = {15},
number = {3},
pages = {314--324},
doi = {10.1002/pmrj.12866}
}
EUVIMED